Mar 4, 2024
- Mar 3, 2025

Strategies to Coordinate the Multidisciplinary Team for Secondary Prevention, Long-Term Treatment, and the Assessment of Bleeding Risk

EARNed Credits

0.5

AMA PRA Category 1 CreditTM

0.5

CNE Contact Hour

0.5

CPE Contact Hour

iStock-1297034329

Overview

This 0.5-hour, Whiteboard Animation Webcast is designed to review collaboration with the multidisciplinary healthcare team for secondary prevention, long term treatment and bleeding risk assessment for patients with VTE.

Who Should Attend

Primary care physicians, internists, family medicine physicians, allied healthcare professionals and other healthcare providers involved in the care of patients with VTE

Provided By

Course Faculty

Charles Pollack, MA, MD, FACEP, FAHA, FACC, FESC
Clinician-Scientist Emergency Medicine University of Mississippi Jackson, Mississippi

Learning Objectives

1

Develop strategies for collaboration with the multidisciplinary healthcare team for secondary prevention, long term treatment and bleeding risk assessment for patients with VTE

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty Relationship Identified With:
Charles V. Pollack Jr., MD Consultant/Advisor: AstraZeneca Pharmaceuticals; eXIthera Pharmaceuticals; Anthos Therapeutics; Milestone Pharmaceuticals; Huyabio; Provepharm US
Grant/Research Support:  Provepharm US

Timothy Hayes, MD, PhD; Charles V. Pollack Jr., MD; Kim Cheramie, MSN, RN-BC; Patrick Hayes and Nicole McMenamin hereby state that they do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity.

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

AcademicCME designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM.

AcademicCME designates this enduring material for a maximum of 0.50 CNE Contact Hours.

AcademicCME designates this continuing education activity for 0.50 CPE Contact Hours (0.05 CEUs) of continuing pharmacy education credit (UAN # JA4008190-0000-24-002-H01-P.)

Learners should only claim credit commensurate with the extent of their participation.

This activity has been supported by an independent educational grant from the Bristol Myers Squibb and Pfizer Alliance.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and the Bristol Myers Squibb and Pfizer Alliance do not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Learners who receive a grade of 100% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
  • CME and CNE credit will be issued appropriate certificate of completion.
  • Others may request a “certificate of completion”.
  1. Learners should claim only the credit commensurate with the extent of their participation in the activity.

For all CE inquiries or special needs, please contact [email protected].

Mar 4, 2024
- Mar 3, 2025

Strategies to Coordinate the Multidisciplinary Team for Secondary Prevention, Long-Term Treatment, and the Assessment of Bleeding Risk

Related Webcast Courses

Cardiology
Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Managemen...
Cardiology
VTE and Anticoagulation – Guideline Updates for 2024
Cardiology
Shared Decision-Making and Patient Education to Promote Adherence to DOACs and Continuity ...